NCT02248753 - Acute Cardioversion Versus Wait And See-approach for Symptomatic Atrial Fibrillation in the Emergency Department | Biotech Hunter

Enrollment

437

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

November 30, 2018

Study Completion Date

December 31, 2019

Conditions

Atrial Fibrillation

Interventions

DRUG

Pharmacological cardioversion - Flecainide

PROCEDURE

Electrical cardioversion

DRUG

Metoprolol

DRUG

Verapamil

DRUG

Digoxin

DRUG

Pharmacological cardioversion - Amiodarone

Trial Locations (15)

Unknown

VU University Medical Center, Amsterdam

Amphia Hospital, Breda

Catharina Ziekenhuis, Eindhoven

Medisch Spectrum Twente, Enschede

University Medical Center Groningen, Groningen

Zuyderland Medical Center, Heerlen

Alrijne Hospital, Leiderdorp

Maastricht University Medical Center, Maastricht

St. Antonius Hospital, Nieuwegein

Franciscus Gasthuis, Rotterdam

Antonius Ziekenhuis, Sneek

HagaZiekenhuis, The Hague

St. Elisabeth - TweeSteden Hospital, Tilburg

Diakonessenhuis, Utrecht

VieCuri Medical Center, Venlo

All Listed Sponsors

collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

Maastricht University Medical Center

OTHER